LAWRENCE, Mass., May 13, 2015 /PRNewswire/ -- NxStage Medical,
Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis
products, today announced that Jeffrey H.
Burbank, Chief Executive Officer, and Mathew Towse, Chief Financial Officer, will
participate in the following schedule of investor
conferences. A webcast of the event will be made available at
http://ir.nxstage.com/ at the time of each conference.
Jefferies 2015 Healthcare Conference
Grand Hyatt Hotel
New York, NY
June 1st at 11:30 a.m. ET
William Blair 35th
Annual Growth Stock Conference
Four Seasons Hotel
Chicago, IL
June 9th at 10:50 a.m. CT
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device
company, headquartered in Lawrence,
Massachusetts, USA, that develops, manufactures and markets
innovative products for the treatment of end-stage renal disease,
or ESRD, and acute kidney failure. For more information on NxStage
and its products, please visit the company's website at
http://www.nxstage.com.
Forward-Looking Statements
This release contains "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
All statements contained in this release that are not clearly
historical in nature are forward-looking, and the words
"anticipate," "believe," "expect," "estimate," "plan," and similar
expressions are generally intended to identify forward-looking
statements. Examples of these forward-looking statements include
statements as to Messrs. Burbank and Towse's plans to present
at these conferences. NxStage specifically disclaims any
obligation to update these forward-looking statements. These
forward-looking statements should not be relied upon as
representing NxStage's expectations or beliefs as of any date
subsequent to the date of this press release.
Contact:
Kristen K. Sheppard,
Esq.
VP, Investor Relations
ksheppard@nxstage.com
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nxstage-announces-second-quarter-2015-investor-conference-schedule-300082305.html
SOURCE NxStage Medical, Inc.